Filing Flows › Milestone Scientific (MLSS) › Q4 2024
Milestone Scientific (MLSS) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 15, 2025
Milestone Scientific (MLSS) reported revenue of $2.0M for the fourth quarter 2024 (Q4 2024), -11% from a year earlier and -20% from the quarter before. Operating margin was -101.4%, net loss $2.0M (101.1% of revenue).
Milestone Scientific, Q4 2024: revenue $2.0M (-11% year over year), operating margin -101.4%, net loss $2.0M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | -20% | -11% |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$1.5M | — | — |
What changed
Revenue was $2.0M in Q4 2024, down 11% year over year and down 20% from the previous quarter. Dental Segment was the largest line at 99% of revenue.
Gross margin was 75.0%, up 8.2 points from a year earlier. Operating costs exceeded revenue by $2.0M, an operating margin of -101.4%. Operating expenses grew 2% against a revenue fall of 11%. The fastest-growing cost line was Research & development (+23%). The quarter ended with a net loss of $2.0M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$1.5M. Non-cash charges added back $9K of depreciation and amortization and $340K of share-based compensation. Working capital and other items added $175K. Capital expenditures of $4K exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Milestone Scientific's revenue in the fourth quarter 2024?
Milestone Scientific (MLSS) reported revenue of $2.0M for the fourth quarter 2024 (Q4 2024), -11% from a year earlier and -20% from the quarter before.
Was Milestone Scientific profitable in the fourth quarter 2024?
Operating loss was $2.0M (-101.4% of revenue) and net loss $2.0M.